Inside informationEnglish
Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Biophytis
- Filed
- 28/08/2025, 06:59
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 079512_20250828